Mr. Speaker, I have a petition to present signed by a large number of senior citizens belonging to the United Senior Citizens of Ontario.
They point out that the safety of consumers and senior citizens in particular is at risk because brand name drug manufacturers are attempting to force generic drug manufacturers to market their equivalent products in a size, shape and colour different from the brand name medication.
Any action that affects the look of generic drugs could endanger the safety of patients through improper use of medicines. Therefore, the petitioners request that Parliament regulate the longstanding Canadian practice of marketing generic drugs in a size, shape and colour which is similar to that of brand name equivalents.